Bio-Rad Laboratories
BIO
$353.64-3.06%
End of day · as of Oct 17, 2026, 2:45 AM ET
Mkt cap
N/A
EV/Sales
N/A
P/E ratio
43.1
FY2025 Revenue
$2.58B
EPS (TTM)
$8.21
Gross Margin (FY2025)
51.87%
Profit Margin (FY2025)
29.42%
Beta
N/A
Div yield
N/A
Sector
N/A
No recent filings in cache.
Bio-Rad Laboratories (BIO) common stock.
Latest reported BIO revenue for 2025-12-31 was $2.58B. Net income was $759.9M. BIO currently screens at trailing P/E 43.1.
Use this BIO research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full BIO income, balance, and cash tables.
Latest cached Bio-Rad Laboratories (BIO) revenue for Dec 31, 2025 was $2.58B. Net income was $759.9M. Statements: https://lician.com/financials/bio
Bio-Rad Laboratories (BIO) trailing P/E is 43.1 on the latest cached fundamentals snapshot.
Bio-Rad Laboratories (BIO) cached previous close $364.82; day range $353.64 – $369.37; volume 205,027. Session quote: https://lician.com/quote/bio
Bio-Rad Laboratories (BIO) latest cached earnings event is "BIO earnings" on Aug 4, 2026. Earnings calendar: https://lician.com/earnings